A randomized trial of the intrauterine contraceptive device vs hormonal contraception in women who are infected with the human immunodeficiency virus
A randomized trial of the intrauterine contraceptive device vs hormonal contraception in women who are infected with the human immunodeficiency virus
复制标题
DOI:
10.1016/j.ajog.2007.03.031
复制
发表时间:
2007-08-01
影响因子:
9.8
通讯作者:
Stringer, Jeffrey A.
中科院分区:
文献类型:
--
作者:
Stringer, Elizabeth M.;Kaseba, Christine;Stringer, Jeffrey A.
OBJECTIVE: The purpose of this study was to determine whether the intrauterine contraceptive device (IUD) is effective and safe among women who are infected with the human immunodeficiency virus (HIV).STUDY DESIGN: We randomly assigned 599 postpartum, HIV-infected women in Zambia to receive either a copper IUD or hormonal contraception and followed them for at least 2 years.RESULTS: Women who were assigned randomly to hormonal contraception were more likely to become pregnant than those who were assigned randomly to receive an IUD ( rate, 4.6/ 100 vs 2.0/ 100 woman-years; hazards ratio, 2.4; 95% Cl, 1.3- 4.7). One woman who was assigned to the IUD experienced pelvic inflammatory disease (crude rate, 0.16/100 woman- years; 95% Cl, 0.004- 868); there was no pelvic in- flammatory disease among those women who were assigned to hormonal contraception. Clinical disease progression (death or CD4+ lymphocyte count dropping below 200 cells/ mu L) was more common in women who were allocated to hormonal contraception (13.2/ 100 woman-years) than in women who were allocated to the IUD (8.6/ 100 woman-years; hazard ratio, 1.5; 95% Cl, 1.04- 2.1).CONCLUSION: The IUD is effective and safe in HIV- infected women. The unexpected observation that hormonal contraception was associated with more rapid HIV disease progression requires urgent further study.